Literature DB >> 18287808

Novel SLC12A3 mutations in Chinese patients with Gitelman's syndrome.

Leping Shao1, Hong Ren, Weiming Wang, Wen Zhang, Xiaopei Feng, Xiao Li, Nan Chen.   

Abstract

BACKGROUND: Inactivating mutations of the SLC12A3 gene are the most common cause of Gitelman's syndrome (GS), a disorder inherited as an autosomal recessive trait. In a minority of cases, GS-like phenotypes are caused by mutations in the CLCNKB gene.
METHODS: We searched for SLC12A3 and CLCNKB gene mutations in 13 Chinese patients (9 males and 4 females, age 35 +/- 14 years) from 8 unrelated families with the clinical and biochemical features of GS. All coding regions, including intron-exon boundaries, were analyzed using PCR followed by direct sequence analysis.
RESULTS: We identified 10 mutations distributed throughout the SLC12A3 gene. Seven are novel variants, including 4 missense mutations (Gly196Val, Cys430Gly, Gly439Val and Leu571Pro), 2 deletions (1384delG and 346-353delACTGATGG) and 1 in-frame insertion (997insCys). Three mutations were recurrent, including 2 missense mutations (Thr60Met and Asp486Asn) and 1 deletion (2883-2884delAG). The homozygous or heterozygous mutation Thr60Met was found in 8 of 13 patients. There were no mutations detected in the CLCNKB gene.
CONCLUSIONS: Thr60Met may be the most common mutation in Chinese patients with GS. Possible specific genotype-phenotype correlations were difficult to identify. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287808     DOI: 10.1159/000117815

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  12 in total

Review 1.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

2.  Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome.

Authors:  Yi-Fen Lo; Kandai Nozu; Kazumoto Iijima; Takahiro Morishita; Che-Chung Huang; Sung-Sen Yang; Huey-Kang Sytwu; Yu-Wei Fang; Min-Hua Tseng; Shih-Hua Lin
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

3.  A Pedigree with c.179 Cytosine to Threonine Missense Mutation of SLC12A3 Gene Presenting Gitelman's Syndrome.

Authors:  Yaerim Kim; Seong Sik Kang; Woo Yeong Park; Kyubok Jin; Dae-Kwang Kim; Seungyeup Han
Journal:  Electrolyte Blood Press       Date:  2016-06-30

Review 4.  A novel SLC12A3 gene homozygous mutation of Gitelman syndrome in an Asian pedigree and literature review.

Authors:  Q Lü; Y Zhang; C Song; Z An; S Wei; J Huang; L Huang; L Tang; N Tong
Journal:  J Endocrinol Invest       Date:  2015-08-11       Impact factor: 4.256

Review 5.  Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport.

Authors:  Jinwei Zhang; Jason K Karimy; Eric Delpire; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2017-07-12       Impact factor: 6.902

6.  Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.

Authors:  Jinwei Zhang; Keith Siew; Thomas Macartney; Kevin M O'Shaughnessy; Dario R Alessi
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

7.  Hypokalemia, hypomagnesemia, hypocalciuria, and recurrent tetany: Gitelman syndrome in a Chinese pedigree and literature review.

Authors:  Ming-Feng Xia; Hua Bian; Hong Liu; Hui-Juan Wu; Zhi-Gang Zhang; Zhi-Qiang Lu; Xin Gao
Journal:  Clin Case Rep       Date:  2017-03-17

8.  Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.

Authors:  Ciaran Richardson; Kei Sakamoto; Paola de los Heros; Maria Deak; David G Campbell; Alan R Prescott; Dario R Alessi
Journal:  J Cell Sci       Date:  2011-03-01       Impact factor: 5.285

9.  Role of the WNK-activated SPAK kinase in regulating blood pressure.

Authors:  Fatema H Rafiqi; Annie Mercier Zuber; Mark Glover; Ciaran Richardson; Stewart Fleming; Sofija Jovanović; Aleksandar Jovanović; Kevin M O'Shaughnessy; Dario R Alessi
Journal:  EMBO Mol Med       Date:  2010-02       Impact factor: 12.137

10.  Glucose tolerance and insulin responsiveness in Gitelman syndrome patients.

Authors:  Tao Yuan; Lanping Jiang; Chen Chen; Xiaoyan Peng; Min Nie; Xuemei Li; Xiaoping Xing; Xuewang Li; Limeng Chen
Journal:  Endocr Connect       Date:  2017-04-21       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.